Company Filing History:
Years Active: 2018
Title: Innovations in Genome Editing by Yan-fang Fu
Introduction
Yan-fang Fu is a prominent inventor based in Malden, MA (US). He has made significant contributions to the field of genome editing, particularly through his innovative work with CRISPR-Cas systems. His research focuses on enhancing the specificity of RNA-guided genome editing, which is crucial for precise genetic modifications.
Latest Patents
Yan-fang Fu holds a patent titled "Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing." This patent addresses the use of guide RNA, which includes a complementarity region that binds to target DNA and a Cas9-binding region to direct a Cas9 nuclease to the target DNA. The patent further discloses methods for increasing the specificity of RNA-guided genome editing by utilizing truncated guide RNAs (tru-gRNAs). He has 1 patent to his name.
Career Highlights
Fu is associated with The General Hospital Corporation, where he continues to advance research in genome editing technologies. His work has implications for various applications in medicine and biotechnology, making him a key figure in the field.
Collaborations
He has collaborated with notable researchers, including J Keith Joung and Jeffry D Sander, to further enhance the impact of his innovations in genome editing.
Conclusion
Yan-fang Fu's contributions to the field of genome editing through his innovative patent work exemplify the potential of CRISPR technology in advancing genetic research. His ongoing efforts continue to shape the future of genetic engineering.